From Yahoo Finance: 2025-03-22 10:20:00

Nike’s Q3 results were slightly better than expected but 9% lower year over year. The road to recovery may not be immediate, impacting Foot Locker’s near-term performance. Jefferies analyst Corey Tarlowe sees encouraging signs with Nike and Foot Locker’s partnership in “Home Court” and “The Clinic” experiences, but significant headwinds lie ahead. Jefferies maintains a Hold rating and $19 price target on Foot Locker shares.



Read more at Yahoo Finance: Nike’s Q3 results could weigh on Foot Locker near-term, says Jefferies